Data Analytics Takes on Medication Management

Billions of dollars are wasted and thousands of lives lost each year through inefficient or ineffective medication management. It has been estimated that the misuse of prescription drugs in our healthcare system is up to a $300 billion problem annually.
Published Online: February 12, 2014

Billions of dollars are wasted and thousands of lives lost each year through inefficient or ineffective medication management. It has been estimated that the misuse of prescription drugs in our healthcare system is up to a $300 billion problem annually.

From the doors of the emergency room to the drawers of patients' home nightstands, medications are mixed up, misremembered, overdosed, underdosed, and laboriously documented or misdocumented.

But things are changing: E-prescribing is now the rule, not the exception. Data analytics is red-flagging areas of concern from the doctor's office to the pharmacy and all throughout the chain of care. And technology is allowing providers to earn hard cash for meeting medication adherence targets.

Read the full story here:http://bit.ly/1g6P6Rf

Source:  Healthcare Leaders Media

 



Feature
Recommended Articles
Approximately 70% of all Medicaid beneficiaries receive their healthcare services through managed care, and state Medicaid programs are required to report encounter data to a national database, but 8 states did not during fiscal year 2011, according to a new government report.
Bruce Feinberg, DO; Scott Gottlieb, MD; and Ted Okon, MBA, discuss the recent establishment of the Oncology Care Model by the CMS and compare its structure with the Community Oncology Alliance’s Oncology Medical Home model.
During this segment, the managed care stakeholders discuss drug spending in oncology and its relation to the overall cost of cancer care. Additionally, they consider which stakeholders should work with pharmaceutical companies during the early stages of drug development, and to what degree stakeholders should collaborate with pharma.
CMS has released additional guidance allowing for flexibility in claims auditing and quality reporting during the transition to the International Classification of Diseases, Tenth Revision and is working with the American Medical Association to educate providers.
New exchange plan enrollees during the first quarter of 2015 spent less on medications than new enrollees during the same time frame 1 year ago